Metabolically associated fatty liver disease
Conditions
Interventions
Qutan Huoxue formula granule group:Gynostemma pentaphylla 20g, White art 12g, turmeric 9g, Rhodiola rosea 6g, raw Hawthorn 15g
Qutan Huoxue formula simulates granules:10% Qutan Huoxue Fang granules, 90% maltodextrin
Sponsors
Ningbo Second Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1. Those who meet the above diagnostic criteria of Chinese and Western medicine; 2. Aged 18-65 years; 3.ALT greater than the upper limit of normal value (male > 50IU/L, female > 40 IU/L), and less than or equal to 5 times the upper limit of normal value; 4. Sign patient informed consent.
Exclusion criteria
Exclusion criteria: 1. Patients who add other liver protection and enzyme lowering drugs in the past 3 months and affect the efficacy evaluation; 2. Alcoholic fatty liver disease (alcohol intake > 20g/d for men and > 10g/d for women), cirrhosis, hepatitis B, hepatitis C and other liver diseases, autoimmune liver disease or taking some drugs that may cause fatty liver disease; 3. Patients with normal liver function; 4. Patients who have had gastrointestinal bariatric surgery in the last year or who have taken weight-loss drugs in the last 3 months have lost more than 10% of their body weight; 5. Age > 65, or < 18; 6. Pregnant and lactating women, primary diseases of cardiovascular, lung, kidney, hematopoietic system and other serious diseases such as malignant tumors.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| ALT;MRI-PDFF; | — |
Secondary
| Measure | Time frame |
|---|---|
| Abdominal Fibroscan CAP value;AST;weight;the waist; | — |
Countries
China
Contacts
Public ContactLi Hongshan
The Second Hospital of Ningbo
Outcome results
None listed